title: Carcinogenic risk of products used in the pharmaceutical and related industries.
abstract: The pharmaceutical industry is perhaps most subject to rules and regulations in the majority of countries. Legislation in France in this regard is flexible and relatively easily adaptable; in addition, the pharmaceutical industry has established its own ground rules. One of these requires that a product be harmless under normal conditions of use; carcinogenicity checks are only mandatory under certain conditions. If they were to be made compulsory, a less unwieldy test system would be required. The use to which a product is put should be taken into consideration in regulating it.
mesh_terms: D000336:Aerosols; D000348:Aflatoxins / Q000009:adverse effects; D001194:Asbestos / Q000009:adverse effects; D002273:Carcinogens / Q000032:analysis; D004396:Coloring Agents / Q000009:adverse effects; D003358:Cosmetics / Q000032:analysis; D003494:Cyclamates / Q000009:adverse effects; D004345:Drug Industry; D004349:Drug Packaging; D005505:Food Coloring Agents / Q000009:adverse effects; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced / Q000209:etiology*; D011143:Polyvinyl Chloride / Q000009:adverse effects; D012439:Saccharin / Q000009:adverse effects; D013549:Sweetening Agents / Q000009:adverse effects; D014752:Vinyl Chloride / Q000009:adverse effects
chemical_list: D000336:Aerosols; D000348:Aflatoxins; D002273:Carcinogens; D004396:Coloring Agents; D003358:Cosmetics; D003494:Cyclamates; D005505:Food Coloring Agents; D013549:Sweetening Agents; D001194:Asbestos; D011143:Polyvinyl Chloride; D012439:Saccharin; D014752:Vinyl Chloride